We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay

News   Sep 13, 2017

 
Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay
 
 
Advertisement
 

RELATED ARTICLES

Variations in Cellular Senescence May Influence Health and Onset of Age-Related Diseases

News

Researchers have proposed that cellular senescence variations during the aging process may lead to control of health and onset of age-related diseases. Based on the characteristics of the secretion of inflammatory cytokines released by aged cells, the team hypothesizes that there are at least four distinct states of cellular senescence and that these states arise from coordinated metabolic and epigenomic alterations.

READ MORE

Scientists Knock-Out All Human Genes To Identify Which Ones SARS-CoV-2 Requires

News

To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a genome-scale, loss-of-function CRISPR screen to systematically knockout all genes in the human genome.

READ MORE

Mapping the Immune Landscape in Pancreatic Cancer To Guide Immunotherapy

News

A new study led by the University of Michigan Rogel Cancer Center combined single-cell RNA sequencing with two other investigative techniques to create a network of interactions that suppress the body's immune response in and around pancreatic tumors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE